Article
Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms.
Experimental hematology - 1 Oct 2014
Prick Janine, de Haan Gerald, Green Anthony R, Kent David G
Abstract excerpt
Myeloproliferative neoplasms (MPNs) are clonal hematological diseases in which cells of the myelo-erythroid lineage are overproduced and patients are predisposed to leukemic transformation. Hematopoietic stem cells are the suspected disease-initiating cells, and these cells must acquire a clonal advantage relative to nonmutant hematopoietic stem cells to perpetuate disease. In 2005, several groups identified a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
